BioSpecifics Technologies Corp.
35 Wilbur Street
Lynbrook,
NY 11563
United States - Map
Phone: 516-593-7000
Fax: 516-593-7039
Web Site: http://www.biospecifics.com
| BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase for multiple indications in the United States. The company has a development and license agreement with Auxilium Pharmaceuticals, Inc. for injectable collagenase known as XIAFLEX for clinical indications in dupuytrens disease, peyronies disease, and frozen shoulder. The XIAFLEX is under phase IIb clinical trial for the treatment of peyronies disease. BioSpecifics Technologies also focuses on the development of collagenase for various other clinical indications, including lipomas and cellulite. The company was founded in 1957 and is headquartered in Lynbrook, New York. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Thomas L. Wegman , 54
Chief Exec. Officer, Pres, Chief Financial Officer, Interim Principal Accounting Officer, Sec., Pres of ABC at Curacao, Pres of ABC at New York, Sec. of ABC at Curacao, Sec. of ABC at New York of ABC at New York |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
Profile
